Background Given the scale of the ongoing COVID-19 pandemic, the development of vaccines
based on different platforms is essential, particularly in light of emerging viral variants, the …

Combination antiretroviral therapy (cART) has led to a very substantial reduction in morbidity
and mortality in HIV‐infected patients; however, cART alone is unable to cure HIV and …

Latently infected resting CD4 + T cells are a major barrier to HIV cure. Understanding how
latency is established, maintained and reversed is critical to identifying novel strategies to …

Background As vaccines against SARS-CoV-2 are now being rolled out, a better understanding
of immunity to the virus, whether from infection, or passive or active immunisation, and …

Due to its small size and versatility, the biarsenical-tetracysteine system is an attractive way
to label viral proteins for live cell imaging. This study describes the genetic labeling of the …

HIV-1 infection is characterized by the rapid generation of genetic diversity that facilitates viral
escape from immune selection and antiretroviral therapy. Despite recombination's crucial …

Background The SARS-CoV-2 global pandemic has fuelled the generation of vaccines at
an unprecedented pace and scale. However, many challenges remain, including: the …

We characterized a persistently Junín virus (JUNV)-infected BHK-21 cell line obtained by
experimental infection with the XJCl3 strain. This cell line, named K3, produced low levels of …

Human immunodeficiency virus type I (HIV-1) is a retrovirus that infects cells of the host’s
immune system leading to acquired immunodeficiency syndrome and potentially death. …

Histone deacetylase inhibitors (HDACi) can induce human immunodeficiency virus (HIV)
transcription from the HIV long terminal repeat (LTR). However, ex vivo and in vivo responses …